Omid Hamid

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Merck
    Topic:
    Consulting / Advisory Board
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Moderna
    Topic:
    Consulting / Advisory Board
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    NGM Bio
    Topic:
    Consulting / Advisory Board
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Novartis
    Topic:
    Consulting / Advisory Board
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Obsidian
    Topic:
    Consulting / Advisory Board
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Pfizer
    Topic:
    Consulting / Advisory Board
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Regeneron
    Topic:
    Consulting / Advisory Board
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Sanofi
    Topic:
    Consulting / Advisory Board
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Seattle Genetics
    Topic:
    Consulting / Advisory Board
    Date added:
    07/01/2024
    Date updated:
    07/01/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Tempus
    Topic:
    Consulting / Advisory Board
    Date added:
    07/01/2024
    Date updated:
    07/01/2024

Pages

Return to 4th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies